LCI - Lannett enters new insulin glargine deal with HEC
- Lannett (NYSE:LCI) says in a filing that it's entered into a new collaboration and license agreement with HEC.
- More news on: Lannett Company, Inc., Healthcare stocks news, Read more ...
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
| Company Name: | Lannett Co Inc |
| Stock Symbol: | LCI |
| Market: | NYSE |
Get LCI Alerts
News, Short Squeeze, Breakout and More Instantly...